Microtia
28
4
6
7
Key Insights
Highlights
Success Rate
58% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
17.9%
5 terminated out of 28 trials
58.3%
-28.2% vs benchmark
7%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (28)
Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Nitrate Modulates Cognitive Impairment Via Oral Microbiota.
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
Safety and Efficacy of Connecting the Residual Ear to the Cartilage Scaffold in First- vs. Second-Stage Surgery
Rib Microtia and the Erector Spinae Plane (ESP) Block
Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
Bisphenol A and Muscle Insulin Sensitivity
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)
AuriNovo for Auricular Reconstruction
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia
Akkermansia and Weight Maintenance
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients